chlorothiazide has been researched along with quinoxalines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertolino, M; Costa, E; DiBella, M; Guidotti, A; Thompson, DM; Uzunov, D; Zivkovic, I | 1 |
1 other study(ies) available for chlorothiazide and quinoxalines
Article | Year |
---|---|
7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
Topics: Alprazolam; Animals; Avoidance Learning; Benzothiadiazines; Brain; Chlorothiazide; Cognition; Diazoxide; Electrophysiology; Glutamates; Ligands; Male; Maze Learning; Phosphatidylinositols; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Muscarinic; Scopolamine; Stereoisomerism; Synaptosomes | 1995 |